C7B — Secondary neuroendocrine tumors
Not billable
Is C7B billable?
No — C7B is a non-billable header code. C7B groups more specific codes and cannot be submitted on a claim. A valid ICD-10-CM code must be reported at the highest level of specificity available in its branch. Select one of the 8 billable codes beneath C7B.
Billable codes under this header
- C7B.1Secondary Merkel cell carcinoma
- C7B.8Other secondary neuroendocrine tumors
- C7B.00Secondary carcinoid tumors, unspecified site
- C7B.01Secondary carcinoid tumors of distant lymph nodes
- C7B.02Secondary carcinoid tumors of liver
- C7B.03Secondary carcinoid tumors of bone
- C7B.04Secondary carcinoid tumors of peritoneum
- C7B.09Secondary carcinoid tumors of other sites
C7B at a glance
| Code | C7B |
|---|---|
| Description | Secondary neuroendocrine tumors |
| Billable | No — header code |
| Code set | ICD-10-CM FY2027 |
| Valid for encounters | October 1, 2026 – September 30, 2027 |
Use additional code
Report an additional code alongside C7B to fully describe the condition. C7B is sequenced first.
- code to identify any functional activity
What codes fall under C7B? (3)
How long has C7B existed?
C7B has been in ICD-10-CM since at least FY2016, the earliest fiscal year on record here.
Derived from the official order files for FY2016–FY2026. FY2017 and FY2020 publish no order file, so those years are not covered.